Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
QIPT Stock Forecast 2025-2026
$1.42
Current Price
$59.21M
Market Cap
Buy 4
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to QIPT Price Targets
+216.9%
To High Target of $4.50
+181.7%
To Median Target of $4.00
+19.7%
To Low Target of $1.70
QIPT Price Momentum
-34.9%
1 Week Change
-28.6%
1 Month Change
-54.9%
1 Year Change
-53.4%
Year-to-Date Change
-65.1%
From 52W High of $4.07
+5.2%
From 52W Low of $1.35
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Quipt (QIPT) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on QIPT and similar high-potential opportunities.
Latest QIPT Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, QIPT has a bullish consensus with a median price target of $4.00 (ranging from $1.70 to $4.50). The overall analyst rating is Strong Buy (8.8/10). Currently trading at $1.42, the median forecast implies a 181.7% upside. This outlook is supported by 4 Buy, 1 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Richard Close at Canaccord Genuity, suggesting a 19.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
QIPT Analyst Ratings
4
Buy
1
Hold
0
Sell
QIPT Price Target Range
Low
$1.70
Average
$4.00
High
$4.50
Current: $1.42
Latest QIPT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for QIPT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 14, 2025 | Benchmark | Bill Sutherland | Buy | Maintains | $4.00 |
| May 13, 2025 | Canaccord Genuity | Richard Close | Hold | Downgrade | $1.70 |
| Aug 21, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $7.00 |
| Aug 16, 2024 | Canaccord Genuity | Richard Close | Buy | Maintains | $6.00 |
| May 20, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $9.00 |
| May 17, 2024 | Canaccord Genuity | Richard Close | Buy | Maintains | $8.00 |
| Feb 16, 2024 | Raymond James | Rahul Sarugaser | Market Perform | Downgrade | $10.00 |
| Dec 20, 2023 | Benchmark | Bill Sutherland | Buy | Reiterates | $10.00 |
| Jun 14, 2023 | Canaccord Genuity | Richard Close | Buy | Assumes | $11.00 |
| May 17, 2023 | Benchmark | Bill Sutherland | Buy | Reiterates | $10.00 |
| Feb 15, 2023 | Benchmark | Bill Sutherland | Buy | Reiterates | $10.00 |
| Feb 13, 2023 | Benchmark | Bill Sutherland | Buy | Reiterates | $10.00 |
| Dec 31, 2021 | Benchmark | Buy | Initiates | $0.00 | |
| Oct 20, 2021 | Benchmark | Buy | Initiates | $0.00 |
Quipt Home Medical Corp. (QIPT) Competitors
The following stocks are similar to Quipt based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Quipt Home Medical Corp. (QIPT) Financial Data
Quipt Home Medical Corp. has a market capitalization of $59.21M with a P/E ratio of 493.0x. The company generates $240.85M in trailing twelve-month revenue with a -3.6% profit margin.
Revenue growth is -6.3% quarter-over-quarter, while maintaining an operating margin of -1.7% and return on equity of -8.1%.
Valuation Metrics
Market Cap
$59.21M
Enterprise Value
$147.21M
P/E Ratio
493.0x
PEG Ratio
-22.8x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
-6.3%
Gross Margin
+71.1%
Operating Margin
-1.7%
Net Margin
-3.6%
EPS Growth
-1.9%
Financial Health
Cash/Price Ratio
+27.8%
Current Ratio
1.2x
Debt/Equity
95.4x
ROE
-8.1%
ROA
-0.3%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Quipt Home Medical Corp. (QIPT) Business Model
About Quipt Home Medical Corp.
What They Do
Provides in-home respiratory care solutions.
Business Model
The company operates by offering durable medical equipment and in-home healthcare services primarily for patients with chronic respiratory needs. It generates revenue through direct patient services, partnerships with healthcare providers, and collaborations with insurance companies to deliver comprehensive care plans.
Additional Information
Quipt Home Medical Corp. has a significant presence in North America, emphasizing accessible healthcare and patient education. Its focus on quality service aligns with the growing trend of home-based care, which aims to improve patient outcomes and reduce healthcare costs.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
1,200
CEO
Mr. Gregory J. Crawford
Country
United States
IPO Year
2000
Website
quipthomemedical.comQuipt Home Medical Corp. (QIPT) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
BioLife Solutions, Inc. (BLFS) Q1 Earnings and Revenues Beat Estimates
BioLife Solutions (BLFS) delivered earnings and revenue surprises of 233.33% and 5.28%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
May 08, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Quipt Home Medical Corp. (NASDAQ: QIPT) will hold its Q2 2025 earnings conference call on May 13, 2025, at 10:00 AM ET, featuring CEO Greg Crawford and CFO Hardik Mehta.
Why It Matters
Quipt Home Medical's Q2 2025 earnings call indicates upcoming financial performance insights, crucial for assessing company health and potential investment risk or opportunity.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Quipt Home Medical Corp. (NASDAQ: QIPT; TSX: QIPT) reported its fiscal Q2 2025 financial results for the period ending March 31, 2025, highlighting its focus on respiratory care.
Why It Matters
Quipt's Q2 2025 financial results can indicate its growth trajectory, operational efficiency, and market position in the home medical equipment sector, influencing investor sentiment and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2025 Financial Results on May 12, 2025
18 days ago
Quick Summary
Quipt Home Medical Corp. (NASDAQ: QIPT) will report its fiscal Q2 2025 results on May 12, 2025, after market close, with a conference call scheduled for May 13 at 10:00 a.m. ET.
Why It Matters
Quipt Home Medical's upcoming earnings announcement and conference call may reveal key financial performance indicators and strategic direction, impacting investor sentiment and stock valuation.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
The company is optimizing its capital allocation, expanding new locations, strengthening referral networks, and pursuing a healthcare system-focused M&A strategy.
Why It Matters
This news indicates strategic growth and potential revenue increase, signaling a positive outlook for future performance and shareholder value enhancement.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Quipt Home Medical Corporation has reached standstill agreements with two activist hedge funds, indicating a focus on maximizing shareholder value, potentially raising QIPT stock to $4-$4.75 per share.
Why It Matters
The standstill agreements indicate potential collaboration between management and activists, suggesting a focus on maximizing shareholder value, which could drive QIPT stock significantly higher.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
The company is focused on executing its growth plans and enhancing shareholder value.
Why It Matters
Commitment to growth and enhancing shareholder value signals potential for future profitability, attracting investment and potentially boosting stock prices.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About QIPT Stock
What is Quipt Home Medical Corp.'s (QIPT) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, Quipt Home Medical Corp. (QIPT) has a median price target of $4.00. The highest price target is $4.50 and the lowest is $1.70.
Is QIPT stock a good investment in 2025?
According to current analyst ratings, QIPT has 4 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.42. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for QIPT stock?
Wall Street analysts predict QIPT stock could reach $4.00 in the next 12 months. This represents a 181.7% increase from the current price of $1.42. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Quipt Home Medical Corp.'s business model?
The company operates by offering durable medical equipment and in-home healthcare services primarily for patients with chronic respiratory needs. It generates revenue through direct patient services, partnerships with healthcare providers, and collaborations with insurance companies to deliver comprehensive care plans.
What is the highest forecasted price for QIPT Quipt Home Medical Corp.?
The highest price target for QIPT is $4.50 from at , which represents a 216.9% increase from the current price of $1.42.
What is the lowest forecasted price for QIPT Quipt Home Medical Corp.?
The lowest price target for QIPT is $1.70 from Richard Close at Canaccord Genuity, which represents a 19.7% increase from the current price of $1.42.
What is the overall QIPT consensus from analysts for Quipt Home Medical Corp.?
The overall analyst consensus for QIPT is bullish. Out of 4 Wall Street analysts, 4 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $4.00.
How accurate are QIPT stock price projections?
Stock price projections, including those for Quipt Home Medical Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 18, 2025 9:53 AM UTC